CGM Cegedim SA

Cegedim: Half-year liquidity contract statement as of 30/06/2020

Cegedim: Half-year liquidity contract statement as of 30/06/2020

CEGEDIM

Public limited company with a capital of € 13 336 506,43

Registered office : 137, rue d’Aguesseau 92100 Boulogne-Billancourt

350 422 622 R.C.S. on the Nanterre Trade and Companies Register

Paris, July 1st 2020

Half-year liquidity contract statement for CEGEDIM

Under the liquidity contract entered into between CEGEDIM and Kepler Cheuvreux, the following resources appeared on the liquidity account on June 30th 2020 :

-     9,025 shares

-     € 133,591.49

-     Number of executions on buy side on semester : 216

-     Number of executions on sell side on semester : 236

-     Traded volume on buy side on semester : 6,135 shares for € 157,719.86

-     Traded volume on sell side on semester : 7,110 shares for € 192,695.80

------------------------------------------------------------

   

As a reminder :

•    the following resources appeared on the last half year statement on December 31st 2019 on the liquidity account :

-     10,000 shares

-     € 98,615.55

-     Number of executions on buy side on semester : 251

-     Number of executions on sell side on semester : 250

-     Traded volume on buy side on semester : 6,287 shares for € 167,028.70    

-     Traded volume on sell side on semester : 8,087 shares for €  221,289.32

                   

------------------------------------------------------------

•    the following resources appeared on the liquidity account when the activity started :

-     0 shares

-     € 250,000.00

The liquidity agreement complies with AMF Decision n° 2018-01 dated 2nd July 2018, introducing liquidity agreements on equity securities as permitted market practice.

o0o

  Buy Side   Sell Side
Number of executions Number of shares Traded volume in EUR Number of executions Number of shares Traded volume in EUR
Total 216 6,135 157,719.86 236 7,110 192,695.80
02/01/2020 - - - 2 125 3,727.50
03/01/2020 2 51 1,494.30 1 1 29.35
06/01/2020 1 50 1,450.00 2 50 1,458.00
07/01/2020 1 1 29.45 1 1 29.45
08/01/2020 1 1 29.50 1 1 29.50
09/01/2020 1 1 29.45 1 1 29.45
10/01/2020 - - - 1 24 714.00
13/01/2020 1 25 733.75 1 25 733.75
14/01/2020 - - - 1 5 147.75
15/01/2020 4 51 1,504.50 1 1 29.75
16/01/2020 - - - 5 314 9,636.66
17/01/2020 - - - 4 57 1,780.11
20/01/2020 - - - 2 25 773.75
22/01/2020 1 1 31.15 1 1 31.15
23/01/2020 4 101 3,071.41 - - -
24/01/2020 - - - 2 79 2,524.05
27/01/2020 1 1 31.40 1 1 31.40
28/01/2020 2 26 793.26 2 11 344.30
29/01/2020 - - - 1 25 790.00
30/01/2020 7 316 9,666.44 1 1 31.15
31/01/2020 2 35 1,051.40 - - -
03/02/2020 3 58 1,728.40 1 5 149.00
05/02/2020 - - - 3 265 8,109.00
06/02/2020 3 9 275.40 1 1 30.60
07/02/2020 2 100 3,050.00 1 25 770.00
11/02/2020 3 26 780.26 2 26 789.10
13/02/2020 - - - 4 38 1,173.82
19/02/2020 1 1 30.95 1 1 30.95
20/02/2020 1 1 30.90 1 1 30.90
24/02/2020 1 25 750.00 - - -
25/02/2020 3 110 3,270.30 1 25 758.75
26/02/2020 5 150 4,309.50 - - -
27/02/2020 4 175 4,901.75 - - -
28/02/2020 9 549 14,224.59 9 265 7,112.60
02/03/2020 7 500 13,035.00 7 625 16,737.50
03/03/2020 1 1 27.15 7 110 3,037.10
04/03/2020 1 1 27.55 2 26 716.30
09/03/2020 5 225 5,586.75 - - -
10/03/2020 2 101 2,483.59 - - -
11/03/2020 5 174 4,158.60 2 25 606.25
12/03/2020 8 85 1,951.60 - - -
13/03/2020 4 50 1,162.50 - - -
16/03/2020 6 245 5,260.15 2 100 2,290.00
17/03/2020 10 328 6,743.68 2 100 2,300.00
18/03/2020 - - - 2 50 1,075.00
19/03/2020 4 76 1,597.52 4 76 1,725.96
20/03/2020 5 71 1,482.48 2 26 624.00
23/03/2020 4 200 3,942.00 3 320 6,806.40
26/03/2020 1 50 1,050.00 1 20 449.00
27/03/2020 1 25 535.00 2 105 2,373.00
30/03/2020 1 10 225.00 5 200 4,762.00



31/03/2020 3 150   3,300.00  3 73 1,744.70
01/04/2020 1 25 562.50   1 5 115.00
02/04/2020 3 51 1,234.71 10 371 9,237.90
03/04/2020 2 26 607.10 2 26 652.08
06/04/2020 - - - 2 26 650.52
07/04/2020 - - - 1 24 612.00
08/04/2020 1 1 25.10 3 51 1,297.44
09/04/2020 - - - 2 200 5,120.00
14/04/2020 1 25 625.00 1 10 261.00
15/04/2020 3 36 874.08 2 26 683.54
16/04/2020 1 10 250.00 4 45 1,151.10
17/04/2020 - - - 6 270 7,335.90
20/04/2020 1 1 26.50 2 21 556.50
21/04/2020 1 1 27.20 4 101 2,747.20
22/04/2020 - - - 2 51 1,438.20
23/04/2020 1 1 27.00 1 1 27.00
24/04/2020 1 1 27.00 1 1 27.00
27/04/2020 1 1 28.20 4 50 1,417.50
28/04/2020 4 276 7,421.64 8 138 3,891.60
29/04/2020 1 1 28.00 3 44 1,296.68
30/04/2020 10 237 6,538.83 2 82 2,287.80
04/05/2020 2 97 2,549.16 - - -
05/05/2020 3 54 1,409.94 1 1 26.30
07/05/2020 2 10 269.00 4 100 2,850.00
08/05/2020 1 1 26.40 1 1 26.40
11/05/2020 2 20 532.00 - - -
12/05/2020 1 100 2,700.00 4 180 4,894.20
14/05/2020 10 287 7,289.80 1 1 27.00
15/05/2020 - - - 4 60 1,558.20
18/05/2020 - - - 2 76 2,039.08
19/05/2020 - - - 3 200 5,380.00
20/05/2020 1 1 26.80 1 1 26.80
21/05/2020 1 1 26.30 1 1 26.30
22/05/2020 1 1 26.40 1 1 26.40
25/05/2020 8 563 14,553.55 1 1 26.70
26/05/2020 3 39 1,006.20 6 601 16,154.88
27/05/2020 - - - 8 150 4,117.50
28/05/2020 1 1 27.20 2 11 307.23
02/06/2020 1 1 27.00 4 56 1,567.44
03/06/2020 1 1 28.40 3 101 2,868.40
04/06/2020 1 1 28.10 4 86 2,472.50
05/06/2020 1 1 29.10 3 126 3,753.54
08/06/2020 1 1 30.40 2 26 787.80
09/06/2020 - - - 4 75 2,259.75
12/06/2020 3 25 700.00 - - -
15/06/2020 1 25 697.50 2 25 710.00
16/06/2020 1 1 28.40 1 1 28.40
17/06/2020 1 1 28.80 1 1 28.80
18/06/2020 1 1 28.60 1 1 28.60
19/06/2020 - - - 1 25 730.00
22/06/2020 - - - 1 1 29.50
23/06/2020 - - - 4 374 11,231.22
24/06/2020 - - - 2 25 747.50
25/06/2020 1 1 28.80 1 1 28.80
26/06/2020 2 26 741.00 1 1 28.70
30/06/2020 2 26 741.52 1 1 28.90

Attachments

EN
03/07/2020

Underlying

CGMCegedim SA

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Cegedim SA

 PRESS RELEASE
Free
CGM CEGEDIM SA

Claude Bernard annonce un partenariat stratégique avec RenAdaptor, exp...

Claude Bernard annonce un partenariat stratégique avec RenAdaptor, expert en adaptation posologique pour l’insuffisance rénale Ensemble, ils unissent leurs expertises pour sécuriser et simplifier la prescription chez les patients atteints d’une insuffisance rénale Boulogne-Billancourt, France, le 15 mai 2025 – Face à une problématique de santé publique majeure, , acteur de référence dans la gestion des bases de données des médicaments et des produits de santé, s’associe à RenAdaptor, expert en adaptation posologique pour l’insuffisance rénale, pour proposer ensemble une solution innovante ...

May 15, 2025 1 EN
Carole Braudeau
  • Carole Braudeau
CGM CEGEDIM SA
UCG UniCredit S.p.A... ... (+5)

Credit Morning 05/12/2025

Pharma: Donald Trump wants to cut the price of prescription drugs|ams OSRAM launches a consent request to amend the convertible notes|MPS published strong Q1 2025 results /the offer for Bacred is proceeding according to schedule|

CGM CEGEDIM SA
UCG UNICREDIT S.P.A.
KGX KION GROUP AG
VRLA VERALLIA SAS
AMS AMS-OSRAM AG
05/12/25 May 12, 2025 1 EN
Carole Braudeau
  • Carole Braudeau
CGM CEGEDIM SA
UCG UniCredit S.p.A... ... (+5)

Morning Crédit 12/05/2025

Pharma : Donald Trump veut réduire le prix des médicaments sur ordonnance|ams OSRAM lance une demande de consentement visant les obligations convertibles|MPS a publié de solides résultats T1 2025 et poursuit son offre sur Mediobanca|

CGM CEGEDIM SA
UCG UNICREDIT S.P.A.
KGX KION GROUP AG
VRLA VERALLIA SAS
AMS AMS-OSRAM AG
05/12/25 May 12, 2025 1 FR
 PRESS RELEASE
Free
CGM CEGEDIM SA

Cegedim: plan to transfer its shares to Euronext Growth Paris.

Cegedim: plan to transfer its shares to Euronext Growth Paris.  PRESS RELEASE Stock market information Boulogne-Billancourt, 9 May 2025 – Cegedim, an innovative technology and services group, announces its plan to transfer its shares to Euronext Growth® Paris. At its next Ordinary Shareholders’ Meeting on 13 June 2025, shareholders will be asked to approve the proposed delisting of CEGEDIM S.A. shares from the Euronext Paris regulated market and their concomitant admission to trading on Euronext Growth, within 12 months of the Shareholders’ Meeting of 13 June 2025. Such a transfer woul...

May 9, 2025 1 EN
 PRESS RELEASE
Free
CGM CEGEDIM SA

Cegedim : projet de transfert de ses actions sur Euronext Growth Paris...

Cegedim : projet de transfert de ses actions sur Euronext Growth Paris.  COMMUNIQUE DE PRESSE Information boursière Boulogne-Billancourt, le 9 mai 2025 - , Groupe innovant de technologies et de services, annonce son projet de transfert de ses actions sur Euronext Growth® Paris. A l’occasion de sa prochaine Assemblée Générale, le 13 juin 2025, il sera demandé aux actionnaires d’approuver le projet de radiation des titres de CEGEDIM S.A. des négociations sur le marché règlementé Euronext Paris et leur admission concomitante sur Euronext Growth, dans un délai de 12 mois à compter de l’Ass...

May 9, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch